Antimyeloperoxidase-antibody-positive rapidly progressive glomerulonephritis associated with Castleman's disease

Nephrology Dialysis Transplantation

Volumn 13, Issue 6, 1998, Pages 1556-1558

  Furuichi, Kengo ^a   Wada, Takashi ^a   Shimizu, Miho ^a   Segawa, Chikako ^a   Ohta, Satoshi ^a   Takasawa, Kazuya ^a   Kobayashi, Ken Ichi ^a   Yokoyama, Hitoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Antimyeloperoxidase antibody; Castleman's disease; Crescentic glomerulonephritis; Immunosuppressants

Indexed keywords

CYCLOPHOSPHAMIDE; ENZYME ANTIBODY; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; ANTIBODY; CREATININE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; METHYLPREDNISOLONE; MYELOPEROXIDASE ANTIBODY; NITROGEN; PREDNISOLONE; UNCLASSIFIED DRUG; UREA;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; CREATININE CLEARANCE; DRUG DOSE REDUCTION; HEMATURIA; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; INGUINAL LYMPH NODE; KIDNEY BIOPSY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MIDDLE AGED; PLASMA CELL; PROTEINURIA; PURPURA; UPPER RESPIRATORY TRACT INFECTION; URINE SEDIMENT;

EID: 0031800511     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.6.1556     Document Type: Article

References (17)

1. Castleman B, Iverson L, Menedez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956; 9: 822-830
2. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670-683
3. Yoshizaki K, Nakagawa T, Furunaga K et al. Pathogenic significance of interleukin-6 in Castleman's disease. Blood 1989; 74: 1360-1367
4. Bruce A, Glauco F. Multicentric Castleman's disease. Semin Oncol 1993; 20: 636-647
5. Humpherys SR, Holley KE, Smith LH et al. Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephrotic syndrome. Mayo Clinic Proc 1975; 50: 317-321
6. Giancarlo R, Paola B, Giuseppe C et al. Membranous nephropathy associated with giant lymph node hyperplasia. Am J Nephrol 1990; 10: 323-328
7. Chan TM, Cheng IKP, Wong KL et al. Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease). Nephron 1993; 65: 628-632
8. Tsukamoto Y, Hanada N, Nomura Y et al. Rapidly progressive renal failure associated with angiofollicular lymph node hyperplasia. Am J Nephrol 1991; 11: 430-436
9. Bonneau R. Angiofollicular lymph node hyperplasia of the plasma cell type with nephrotic Syndrome and systemic amyloidosis (abstract). Lab Invest 1982; 46: 10A-11A
10. Chan KW, Chan MK, Choy DTK. Nephrotic syndrome associated with angiofollicular lymph node hyperplasia. Pathology 1987; 19: 429-432
11. Riyad S, Mesleh T. Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymphs node hyperpiasia. Am J Nephrol 1992; 12: 466-470
12. Voshida Y, Hara Y, Sato T et al. A case of idiopathic plasmasytic lymphadenopathy with polyclonal hyperimmunoglobulinemia. Intern Med 1989; 78: 1324-1328
13. Falk RJ, Jennette JC. Anti-neuirophil cytoplasmic autoantibodies With specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis, N Engl J Med 1988; 318: 1651-1657
14. Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 1992; 62: S60-S65
15. Auphan N, DiDonato JA, Rosette C et al. Immunosupression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286-290
16. Scheinman RI, Cogswell PC, Lofquist AK et al. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286
17. Thomas W, Roel DR. Glucocoiticoids and immune function: unknown dimensions and new frontiers. Immunol Today 1997; 18: 418-424